Prot #DMVT-505-2104: Open Label Maximal Use Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Tapinarof Cream, 1% in Pediatric Subjects with Extensive Atopic Dermatitis

Project: Research project

Project Details

StatusFinished
Effective start/end date12/22/21 → 12/22/24

Funding

  • SynteractHCR, Inc. ((OE) Prot #DMVT-505-2104 // (OE) Prot #DMVT-505-2104)
  • Dermavant Sciences, Inc ((OE) Prot #DMVT-505-2104 // (OE) Prot #DMVT-505-2104)